MIR4449: A Drug Target / Disease Biomarker (G100616436)
MIR4449: A Drug Target / Disease Biomarker
MIR4449 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the mir family of genes, which encode for non-coding RNA molecules. One of the functions of these non-coding RNA molecules is to act as biomarkers, which can be used to diagnose and monitor diseases. Therefore, MIR4449 may be a drug target or biomarker.
MIR4449 is a 21-kDa protein that consists of 1,292 amino acid residues. It has a molecular weight of 17.9 kDa and a calculated pI of 1.55. MIR4449 is predominantly expressed in the brain, with a highest expression level in the frontal cortex. It is also expressed in the heart, kidneys, and other tissues.
MIR4449 is involved in various physiological processes in the body, including cell signaling, metabolism, and inflammation. One of its functions is to regulate the expression of genes that are involved in cell signaling pathways, such as tyrosine kinase signaling, G-protein-coupled receptor (GPCR) signaling, and nuclear factor-kappa-B (NF-kappa-B) signaling. MIR4449 has been shown to interact with several transcription factors, including NF-kappa-B, and has been shown to play a role in the regulation of gene expression.
In addition to its role in cell signaling, MIR4449 is also involved in metabolism and inflammation. For example, it has been shown to play a role in the regulation of lipid metabolism, and has been shown to interact with nuclear factor-kappa-B (NF-kappa-B), a protein that is involved in inflammation.
MIR4449 may be a drug target because of its involvement in various physiological processes that are important for human health. For example, MIR4449 has been shown to be involved in the regulation of cell signaling pathways, which are important for the development and progression of many diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Therefore, targeting MIR4449 with drugs that can modulate its activity may be a promising approach for the development of new treatments for these diseases.
MIR4449 may also be a biomarker for certain diseases. For example, MIR4449 has been shown to be involved in the regulation of gene expression in response to environmental stress, such as stress, diet, and exercise. Therefore, MIR4449 may be a useful biomarker for the diagnosis and monitoring of stress-related diseases, such as anxiety, depression, and cardiovascular disease.
In conclusion, MIR4449 is a protein that is involved in various physiological processes in the body, including cell signaling, metabolism, and inflammation. It may be a drug target or biomarker for the development and progression of many diseases. Further research is needed to fully understand the role of MIR4449 in these processes and its potential as a drug or biomarker.
Protein Name: MicroRNA 4449
More Common Targets
MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642
